Journals / Turkish Journal of Rheumatology(.)Archives of Rheumatology / 2012 / Cilt: 27 - Sayı: 4

Ailesel Akdeniz Ateşinde Spondilit ve Artrit

Spondylitis and Arthritis in Familial Mediterranean Fever

Pages
241–247
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although colchicine therapy is effective in preventing attacks and amyloidosis, both disease-modifying antirheumatic drugs (DMARDs) and biological drugs appear to be effective in treating severe forms of rheumatological disorders and chronic erosive arthritis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to evaluate the clinical features of patients who are diagnosed with familial Mediterranean fever (FMF) and followed due to arthritis/spondylitis findings.
📊
Key Findings & Data:Patients and methods: The data of 29 patients (12 males, 17 females; mean age 26.1±11.2 years; range 16 to 51 years) who presented with arthritis and/or inflammatory spinal pain and were diagnosed with FMF between November 2000 and March 2012 were retrospectively analyzed.
💡
Conclusion & Impact:Although colchicine therapy is effective in preventing attacks and amyloidosis, both disease-modifying antirheumatic drugs (DMARDs) and biological drugs appear to be effective in treating severe forms of rheumatological disorders and chronic erosive arthritis
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to evaluate the clinical features of patients who are diagnosed with familial Mediterranean fever (FMF) and followed due to arthritis/spondylitis findings. Patients and methods: The data of 29 patients (12 males, 17 females; mean age 26.1±11.2 years; range 16 to 51 years) who presented with arthritis and/or inflammatory spinal pain and were diagnosed with FMF between November 2000 and March 2012 were retrospectively analyzed. The age and gender of the patients were recorded. The age of onset of arthritis/spondylitis, age at FMF diagnosis, family history of FMF, and previous surgical history as well as the number of affected joints and their localization were also recorded. The presence of peripheral arthritis in patients with sacroiliitis and spondylitis was also investigated, and the drugs used for treatment were recorded. The results were documented in patients who underwent human leukocyte antigen (HLA)-B27 and Mediterranean fever (MEFV) gene analysis. Results: The mean age of onset of arthritis/spondylitis was 20.4±9.1 years. Arthritis was observed in 24 of the patients (monoathritis in 15 patients, oligoarthritis in 9 patients), and the most affected peripheral joint was the ankle (n=13). Five patients had both arthritis and spondylitis while five others had only spondylitis. Four patients had a history of total hip replacement, one with knee debridement, and one with an appendectomy. The Mediterranean fever gene analysis was performed on 27 patients, and 10 of them (37%) had a M694V homozygous mutation, and those who had undergone total hip replacement had the same mutation. The HLA-B27 gene analysis was performed on 21 patients, and two of them tested positive. Conclusion: Familial Mediterranean fever should be included in the differential diagnosis of inflammatory arthritis and spondylitis in young patients. Classical arthritis attacks are the most common clinical presentation; however, chronic erosive joint involvement and spondylitis should be also recognized as clinical features of the disease. Although colchicine therapy is effective in preventing attacks and amyloidosis, both disease-modifying antirheumatic drugs (DMARDs) and biological drugs appear to be effective in treating severe forms of rheumatological disorders and chronic erosive arthritis

Özet

Amaç: Bu çalışmada ailesel Akdeniz ateşi (AAA) tanısı olan ve artrit/spondilit bulgusu ile takip edilen hastaların klinik özellikleri incelendi.Hastalar ve yöntemler: Kasım 2000 - Mart 2012 tarihleri arasında artrit veya inflamatuvar omurga ağrısı yakınması ile başvuran ve AAA tanısı konmuş 29 hastanın (12 erkek, 17 kadın; ort. yaş 26.1±11.2 yıl; dağılım 16-51 yıl) verileri retrospektif olarak incelendi. Hastaların yaş ve cinsiyetleri kaydedildi. Artrit/spondilit başlangıç yaşı, AAA tanı yaşı, ailede AAA öyküsü ve geçirilmiş cerrahi girişim öyküsü varlığının yanı sıra, periferik artriti bulunan hastaların tutulan eklem sayısı ve yeri de kaydedildi. Sakroiliit ve spondiliti bulunan hastalarda periferik artrit varlığı incelendi ve tedavide kullanılan ilaçlar kaydedildi. İnsan lökosit antijen (HLA)-B27 ve Akdeniz ateşi (MEFV) geni analizi yapılmış hastaların sonuçları kaydedildi.Bulgular: Artrit/spondilit başlangıç yaşı ortalama 20.4±9.1 yıl idi. Hastaların 24'ünde artrit (15'inde monoartrit, 9'unda oligoartrit) mevcuttu ve en sık etkilenen periferik eklem, ayak bileği idi (n=13). Beş hastada artritle birlikte spondilit, diğer beş hastada sadece spondilit mevcuttu. Dört hastada total kalça replasmanı, bir hastada diz debridmanı ve bir hastada apendektomi öyküsü vardı. Akdeniz ateşi geni analizi yapılan 27 hastanın 10'unda M694V homozigot mutasyonu (%37) saptandı ve total kalça replasmanı cerrahisi geçiren hastaların tümünde aynı mutasyon vardı. HLA-B27 gen incelemesi yapılan 21 hastanın ikisinde HLAB27 pozitif idi.Sonuç: Ailesel Akdeniz ateşi genç hastalarda inflamatuvar artrit ve spondilit ayırıcı tanısında mutlaka yer almalıdır. Klasik artrit atakları en sık görülen klinik tablo olsa da kronik eroziv eklem tutulumu ve spondilitin de bu hastalığın bir klinik görünümü olduğu akılda tutulmalıdır. Kolşisin tedavisi atakların ve amiloidozun önlenmesinde etkili olmakla birlikte, kronik eroziv artritlerde olduğu gibi romatolojik hastalıkların ağır formlarında kullanılan hastalık modifiye edici antiromatizmal ilaçlar (DMARD) ve biyolojik ilaçlar da etkin tedavi seçenekleri olarak görülmektedir

🔖

Cite This Article

SARIKAYA, S., ÖZDOLAP, Ş., MARAŞLI, E. (2012). Ailesel Akdeniz Ateşinde Spondilit ve Artrit. Turkish Journal of Rheumatology(.)Archives of Rheumatology, Cilt: 27 - Sayı: 4, 241–247. https://ajindex.com/articles/375981

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Booth DR, Lachmann HJ, Gillmore JD, Booth SE, Hawkins PN. Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148. QJM 2001;94:527-31.
  2. Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore) 1998;77:268-97.
  3. Cazeneuve C, Dode C, Delpech M, Touitou I, Grateau G, Amselem S. French Society for Human Genetics. "Genetics in Practice" Commission. Core scientific data of use in genetic counseling. Familial Mediterranean fever. Ann Genet 1999;42:241-5. [Abstract] Pras E, Aksentijevich I, Levy E, Gruberg L, Prosen L, Dean M, et al. The gene causing familial Mediterranean fever maps to the short arm of chromosome 16 in Druze and Moslem Arab families. Hum Genet 1994;94:576-7.
  4. Langevitz P, Livneh A, Zemer D, Shemer J, Pras M. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum 1997;27:67-72.
  5. Garcia-Gonzalez A, Weisman MH. The arthritis of familial Mediterranean fever. Semin Arthritis Rheum 1992;22:139-50.
  6. Ince E, Cakar N, Tekin M, Kendirli T, Ozkaya N, Akar N, et al. Arthritis in children with familial Mediterranean fever. Rheumatol Int 2002;21:213-7.
  7. Lidar M, Kedem R, Mor A, Levartovsky D, Langevitz P, Livneh A. Arthritis as the sole episodic manifestation of familial Mediterranean fever. J Rheumatol 2005;32:859-62.
  8. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 2005;84:1-11. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997;90:797-807.
  9. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003;48:1149-55.
  10. Kaşifoğlu T, Calişir C, Cansu DU, Korkmaz C. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol 2009;28:41-6. Onen F. Familial Mediterranean fever. Rheumatol Int 2006;26:489-96.
  11. Sayarlioglu M, Cefle A, Inanc M, Kamali S, Dalkilic E, Gul A, et al. Characteristics of patients with adul